###begin article-title 0
###xml 56 57 56 57 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
Essential role of Notch signaling in effector memory CD8+ T cell-mediated airway hyperresponsiveness and inflammation
###end article-title 0
###begin p 1
###xml 33 49 33 49 <email xmlns:xlink="http://www.w3.org/1999/xlink">gelfande@njc.org</email>
CORRESPONDENCE Erwin W. Gelfand: gelfande@njc.org
###end p 1
###begin p 2
This article is distributed under the terms of an Attribution-Noncommercial-Share Alike-No Mirror Sites license for the first six months after the publication date (see ). After six months it is available under a Creative Commons License (Attribution-Noncommercial-Share Alike 3.0 Unported license, as described at ).
###end p 2
###begin p 3
###xml 39 40 39 40 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 90 91 90 91 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 96 99 96 99 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 194 197 194 197 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 280 283 280 283 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 322 323 322 323 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 347 350 347 350 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 489 492 485 488 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 587 590 583 586 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 760 763 756 759 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 1284 1285 1276 1277 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 199 203 <span type="species:ncbi:10090">mice</span>
###xml 591 595 <span type="species:ncbi:10090">mice</span>
###xml 655 659 <span type="species:ncbi:10090">mice</span>
###xml 813 817 <span type="species:ncbi:10090">mice</span>
Adoptive transfer of in vivo-primed CD8+ T cells or in vitro-generated effector memory CD8+ T (TEFF) cells restores airway hyperresponsiveness (AHR) and airway inflammation in CD8-deficient (CD8-/-) mice. Examining transcription levels, there was a strong induction of Notch1 in TEFF cells compared with central memory CD8+ T cells. Treatment of TEFF cells with a gamma-secretase inhibitor (GSI) strongly inhibited Notch signaling in these cells, and after adoptive transfer, GSI-treated TEFF cells failed to restore AHR and airway inflammation in sensitized and challenged recipient CD8-/- mice, or to enhance these responses in recipient wild-type (WT) mice. These effects of GSI were also associated with increased expression of the Notch ligand Delta1 in TEFF cells. Treatment of sensitized and challenged WT mice with Delta1-Fc resulted in decreased AHR and airway inflammation accompanied by higher levels of interferon gamma in bronchoalveolar lavage fluid. These results demonstrate a role for Notch in skewing the T cell response from a T helper (Th)2 to a Th1 phenotype as a consequence of the inhibition of Notch receptor activation and the up-regulation of the Notch ligand Delta1. These data are the first to show a functional role for Notch in the challenge phase of CD8+ T cell-mediated development of AHR and airway inflammation, and identify Delta1 as an important regulator of allergic airway inflammation.
###end p 3
###begin p 4
###xml 212 214 208 210 <sub xmlns:xlink="http://www.w3.org/1999/xlink">CM</sub>
###xml 234 235 230 231 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 240 243 236 239 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 264 265 260 261 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
Abbreviations used: AHR, airway hyperresponsiveness; BAL, bronchoalveolar lavage; GSI, gamma-secretase inhibitor; MCh, methacholine; MNC, mononuclear cell; NICD, Notch intracellular domain; RL, lung resistance; TCM, central memory CD8+ T; TEFF, effector memory CD8+ T.
###end p 4
###begin p 5
###xml 264 265 264 265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib1">1</xref>
###xml 323 324 323 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib2">2</xref>
###xml 325 326 325 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib5">5</xref>
###xml 376 377 376 377 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 720 721 720 721 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib6">6</xref>
###xml 678 682 <span type="species:ncbi:10090">mice</span>
Asthma is a multifactorial inflammatory disorder arising as a result of the cellular and molecular responses induced by allergen exposure in sensitized hosts. Allergic asthma is characterized by persistent airway inflammation and airway hyperresponsiveness (AHR) (1). From several clinical and experimental investigations (2-5), antigen-specific memory T cells, especially CD4+ T cells, were shown to play an integral role in orchestrating the disease process through the secretion of a variety of Th2 cytokines, including IL-4, IL-5, and IL-13, which induce the development of AHR and eosinophilic inflammation. It has also been reported that the transfer of Th2-type cells in mice induces airway eosinophilia and AHR (6).
###end p 5
###begin p 6
###xml 65 66 65 66 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 127 128 127 128 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 189 190 189 190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib7">7</xref>
###xml 233 234 233 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib8">8</xref>
###xml 277 278 277 278 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 384 385 384 385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib9">9</xref>
###xml 480 481 480 481 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 486 489 486 489 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 657 659 657 659 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib10">10</xref>
###xml 711 712 711 712 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 774 775 774 775 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 821 823 821 823 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib11">11</xref>
###xml 932 933 932 933 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 943 945 943 945 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib12">12</xref>
###xml 947 949 947 949 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib13">13</xref>
###xml 179 187 <span type="species:ncbi:9606">patients</span>
###xml 651 655 <span type="species:ncbi:10090">mice</span>
In addition, there is now increasing evidence for the role of CD8+ T cells in these responses as well. Increased numbers of CD8+ T cells have been shown in the lungs of asthmatic patients (7) and in animal models of allergic asthma (8). We demonstrated that allergen-primed CD8+ T cells were essential for the full development of AHR and airway inflammation through IL-13 production (9). Subsequently, we also reported that in vitro-generated allergen-specific effector memory CD8+ T (TEFF) cells contributed to these responses in the challenge phase through their migration into lung tissue and local production of IL-13 in sensitized and challenged mice (10). We recently demonstrated the critical role of CD4+ T cells in the sensitization phase for the development of CD8+ T cell-mediated AHR and airway inflammation (11). There are numerous articles addressing the molecules that regulate effector functions or activation of CD8+ T cells (12, 13).
###end p 6
###begin p 7
###xml 94 96 94 96 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib14">14</xref>
###xml 280 282 280 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib14">14</xref>
###xml 798 800 794 796 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib14">14</xref>
###xml 801 803 797 799 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib16">16</xref>
###xml 888 890 884 886 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib17">17</xref>
###xml 892 894 888 890 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib18">18</xref>
###xml 1119 1121 1111 1113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib19">19</xref>
The Notch signaling pathway plays a fundamental role in cell fate decisions in all organisms (14). In mammals, there are four identified Notch receptors (Notch1-4) and five ligands of the Delta-like families (Delta1, Delta3, and Delta4) and Jagged families (Jagged1 and Jagged2) (14). Notch receptors and their ligands are also expressed on the surface of mature lymphocytes and APCs. Notch proteins are transcriptional activators expressed first as transmembrane heterodimeric surface receptors. After ligation, Notch undergoes proteolytic processing, including a final cleavage by gamma-secretase to release the Notch intracellular domain (NICD), which translocates to the nucleus and binds to CSL/RBP-J transcription factor, converting it from a repressor to an activator of gene transcription (14-16). Several target genes of Notch, including Hes1, Hes5, and pT have been identified (17, 18). gamma-secretase inhibitors (GSIs) can effectively prevent the enzymatic cleavage of the cytoplasmic domain of Notch receptors, thereby inhibiting the downstream signaling events triggered by activation of these receptors (19).
###end p 7
###begin p 8
###xml 55 57 55 57 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib20">20</xref>
###xml 58 60 58 60 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib23">23</xref>
###xml 83 85 83 85 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib24">24</xref>
###xml 86 88 86 88 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib26">26</xref>
###xml 178 179 178 179 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 181 184 181 184 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 338 339 338 339 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 341 344 341 344 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
Recently, studies have implicated Notch in activation (20-23) and differentiation (24-26) of cells of the peripheral immune system. The role of Notch signaling, especially in CD8+ TEFF cells, and its involvement in allergen-induced AHR and airway inflammation have not been defined. In this study, we demonstrated Notch1 expression on CD8+ TEFF cells and that inhibition of Notch signaling using GSI reversed their effects on development of AHR and airway inflammation, in part due to the up-regulation of IFN-gamma production. Further, we showed that Delta1, a Notch ligand, is an effective inhibitor of allergen-induced AHR.
###end p 8
###begin title 9
RESULTS
###end title 9
###begin title 10
###xml 24 27 24 27 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 60 61 60 61 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 66 68 66 68 <sub xmlns:xlink="http://www.w3.org/1999/xlink">CM</sub>
Notch1 is expressed in TEFF cells but not central memory CD8+ T (TCM) cells
###end title 10
###begin p 11
###xml 85 88 85 88 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 169 170 169 170 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 249 250 249 250 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 252 255 252 255 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 273 274 273 274 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 276 278 276 278 <sub xmlns:xlink="http://www.w3.org/1999/xlink">CM</sub>
###xml 286 288 286 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib10">10</xref>
###xml 346 349 346 349 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 556 559 556 559 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 565 567 565 567 <sub xmlns:xlink="http://www.w3.org/1999/xlink">CM</sub>
###xml 716 719 716 719 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 725 727 725 727 <sub xmlns:xlink="http://www.w3.org/1999/xlink">CM</sub>
###xml 788 791 788 791 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 837 839 837 839 <sub xmlns:xlink="http://www.w3.org/1999/xlink">CM</sub>
###xml 858 866 858 866 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 A</xref>
###xml 948 951 948 951 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 89 93 <span type="species:ncbi:10090">mice</span>
###xml 115 119 <span type="species:ncbi:10090">mice</span>
We previously showed that the development of AHR and eosinophilic inflammation in CD8-/- mice was lower than in WT mice but could be fully restored after transfer of CD8+ T cells from antigen-primed donors or after transfer of in vitro-generated CD8+ TEFF cells but not CD8+ TCM cells (10). Reconstitution of heightened airway responsiveness by TEFF cells was paralleled by restoration of bronchoalveolar lavage (BAL) and tissue eosinophilia, BAL IL-13 levels, and goblet cell metaplasia. To determine if there were differences in gene expression between TEFF and TCM cells, microarray analysis was performed (the microarray data have been deposited in the GEO database under accession number ). In the analysis of TEFF and TCM cell total RNA, an up-regulation of Notch1 was detected in TEFF cells, which was >1,000-fold higher than in TCM cells (P < 0.05) (Fig. 1 A). In contrast, the expression of Notch2 and Notch3 was only minimally higher in TEFF cells.
###end p 11
###begin p 12
###xml 46 47 46 47 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 49 52 49 52 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 0 59 0 59 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Notch receptor expression and signaling in CD8<sup>+</sup> T<sub>EFF</sub> cells.</bold>
###xml 117 120 117 120 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 129 131 129 131 <sub xmlns:xlink="http://www.w3.org/1999/xlink">CM</sub>
###xml 167 170 167 170 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 176 178 176 178 <sub xmlns:xlink="http://www.w3.org/1999/xlink">CM</sub>
###xml 443 446 443 446 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 455 458 455 458 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
Notch receptor expression and signaling in CD8+ TEFF cells. (A) Relative gene expression of Notch family members in TEFF versus TCM cells. The expression of Notch on TEFF and TCM cells was determined by gene chip analysis. The relative gene expression difference for the hybridization signal is depicted as a ratio. #, P < 0.05 summarizing the results of three separate experiments performed in duplicate. (B) Notch signaling is activated in TEFF cells. TEFF cells were stimulated with anti-CD3 and anti-CD28 or SIINFEKL for 24 h after incubation of the cells with DMSO or GSI. Cell lysates were analyzed for the expression of Notch1 by Western blotting, and beta-actin was used as a loading control. One representative of three similar experiments is shown.
###end p 12
###begin p 13
###xml 66 69 66 69 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 129 137 129 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 B</xref>
###xml 238 240 238 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib28">28</xref>
###xml 454 456 454 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib27">27</xref>
###xml 493 494 493 494 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 496 499 496 499 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
Because Notch is not up-regulated and NICD is not detected until TEFF cells are activated through the antigen receptor (or TCR) (Fig. 1 B), Notch1 expression is not retained on the surface after stimulation and is down-regulated by 72 h (28). To effectively maintain GSI interference in transferred cells, we used a secondary challenge protocol in which the analysis of AHR was completed within 48 h of a single provocative secondary allergen challenge (27) and transfer of GSI-transferred CD8+ TEFF cells.
###end p 13
###begin title 14
###xml 34 37 34 37 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
Notch1 signaling is activated in TEFF cells after engagement of the TCR
###end title 14
###begin p 15
###xml 34 35 34 35 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 37 40 37 40 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 395 397 391 393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib29">29</xref>
###xml 399 401 395 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib30">30</xref>
###xml 407 408 403 404 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 410 413 406 409 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 715 723 710 718 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 B</xref>
###xml 758 761 753 756 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 1157 1158 1152 1153 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1160 1163 1155 1158 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 469 473 <span type="species:ncbi:10090">mice</span>
To confirm Notch1 signaling in CD8+ TEFF cells, we examined Notch1 protein cleavage. Engagement of Notch by any of its ligands results in proteolytic cleavage at an intracellular site between glycine 1743 and valine 1744. This cleavage event, which results in the liberation of NICD, is dependent on the enzymatic activity of the gamma-secretase complex that contains presenilins and nicastrin (29, 30). CD8+ TEFF cells isolated from the lymph nodes or spleens of OT-1 mice were stimulated with anti-CD3 plus anti-CD28 or SIINFEKL peptide in the presence of DMSO (vehicle) or 20 muM GSI for 24 h. The cell lysates were analyzed by Western blotting for the cleaved form of Notch1 using a cleavage-specific antibody (Fig. 1 B). Cleaved Notch1 was detected in TEFF cells cultured with either anti-CD3 plus anti-CD28 or SIINFEKL. Treatment with GSI dramatically reduced the levels of cleaved Notch1 protein after TCR or antigen-specific activation. Examination of cell proliferation and cell survival showed no effect of GSI treatment on these parameters (unpublished data). These data demonstrate that Notch1 signaling can be inhibited pharmacologically in CD8+ TEFF cells activated through the TCR.
###end p 15
###begin title 16
###xml 28 31 28 31 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 92 96 <span type="species:ncbi:10090">mice</span>
Effects of transfer of GSI-TEFF cells on allergen-induced AHR and airway inflammation in WT mice
###end title 16
###begin p 17
###xml 105 106 105 106 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 108 111 108 111 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 132 135 132 135 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 151 154 151 154 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 427 435 427 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 A</xref>
###xml 477 479 477 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib31">31</xref>
###xml 481 489 481 489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 A</xref>
###xml 550 553 550 553 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 569 572 569 572 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 688 691 688 691 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 722 725 722 725 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 796 799 796 799 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 833 836 833 836 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 897 900 897 900 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 1059 1067 1059 1067 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 B</xref>
###xml 1144 1147 1144 1147 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 1182 1185 1182 1185 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 1290 1293 1290 1293 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 1336 1339 1336 1339 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 1354 1357 1354 1357 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 222 226 <span type="species:ncbi:10090">mice</span>
###xml 308 312 <span type="species:ncbi:10090">mice</span>
###xml 359 363 <span type="species:ncbi:10090">mice</span>
###xml 776 780 <span type="species:ncbi:10090">mice</span>
###xml 1163 1167 <span type="species:ncbi:10090">mice</span>
###xml 1201 1205 <span type="species:ncbi:10090">mice</span>
###xml 1431 1435 <span type="species:ncbi:10090">mice</span>
To assess the effects of the Notch signaling pathway on the enhancement of the functional activity of CD8+ TEFF cells in vivo, GSI-TEFF cells or DMSO-TEFF cells were transferred into sensitized and challenged recipient WT mice before secondary OVA challenge. Secondary challenge of sensitized and challenged mice led to the development of increased AHR in WT mice, illustrated by significant increases in lung resistance (RL) (Fig. 2 A), as described previously in this model (31).Fig. 2 A also illustrates the changes in RL in WT recipients of GSI-TEFF cells or DMSO-TEFF cells undergoing secondary challenge. AHR to methacholine (MCh) was significantly increased in recipients of DMSO-TEFF cells, but recipients of GSI-TEFF cells failed to increase AHR over that seen in WT mice not receiving TEFF cells. Indeed, transfer of DMSO-TEFF cells significantly increased AHR, whereas transfer of GSI-TEFF cells inhibited the response to a modest degree. In parallel to the assessment of lung function, the inflammatory cell composition of BAL fluid was examined (Fig. 2 B). Eosinophil numbers in BAL fluid were significantly increased in the DMSO-TEFF cell recipient mice, whereas GSI-TEFF cell recipient mice did not show such increases. In contrast, neutrophil numbers were increased in GSI-TEFF cell recipients. Transfer of either DMSO-TEFF cells or GSF TEFF cells increased lymphocyte numbers in BAL fluid compared with WT control mice after secondary allergen challenge.
###end p 17
###begin p 18
###xml 17 20 17 20 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 0 85 0 85 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Transfer of GSI-T<sub>EFF</sub> cells fails to enhance lung allergic responses in WT recipients.</bold>
###xml 134 137 134 137 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 147 150 147 150 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 483 484 481 482 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 557 560 555 558 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 605 608 603 606 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 715 718 713 716 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 745 748 743 746 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 829 832 815 818 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 920 923 906 909 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 960 961 946 947 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 969 970 955 956 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1056 1059 1030 1033 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 1147 1150 1121 1124 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 1243 1246 1217 1220 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 1256 1259 1230 1233 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 1317 1320 1291 1294 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 1347 1350 1321 1324 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 1431 1434 1393 1396 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 1522 1525 1484 1487 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 1967 1970 1927 1930 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 2003 2006 1963 1966 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 115 119 <span type="species:ncbi:10090">mice</span>
###xml 207 211 <span type="species:ncbi:10090">mice</span>
###xml 592 596 <span type="species:ncbi:10090">mice</span>
###xml 864 868 <span type="species:ncbi:10090">mice</span>
###xml 947 951 <span type="species:ncbi:10090">mice</span>
###xml 1091 1095 <span type="species:ncbi:10090">mice</span>
###xml 1174 1178 <span type="species:ncbi:10090">mice</span>
###xml 1219 1223 <span type="species:ncbi:10090">mice</span>
###xml 1466 1470 <span type="species:ncbi:10090">mice</span>
###xml 1557 1561 <span type="species:ncbi:10090">mice</span>
###xml 1988 1992 <span type="species:ncbi:10090">mice</span>
###xml 2024 2028 <span type="species:ncbi:10090">mice</span>
###xml 2043 2047 <span type="species:ncbi:10090">mice</span>
Transfer of GSI-TEFF cells fails to enhance lung allergic responses in WT recipients. Sensitized and challenged WT mice received GSI-TEFF or DMSO-TEFF cells before secondary challenge (OVA/OVA/OVA). Control mice were those that were sensitized and challenged but received PBS at the time of secondary challenge (OVA/OVA/PBS). (A) RL values were obtained in response to increasing concentrations of inhaled MCh, as described in Materials and methods. Data represent the mean +/- SEM (n = 12 in each group). #, significant difference (P < 0.05) between DMSO-TEFF cell recipients and WT control mice or GSI-TEFF cell recipients. (B) Cellular composition of BAL fluid. #, significant difference (P < 0.05) between GSI-TEFF cell recipients and DMSO-TEFF cell recipients; double dagger, significant difference (P < 0.05) between DMSO-TEFF cell recipients and WT control mice; *, significant difference (P < 0.05) between GSI-TEFF cell recipients and WT mice. (C) CD4+ and CD8+ T cells in BAL fluid. double dagger, significant difference (P < 0.05) between DMSO-TEFF cell recipients and WT control mice; *, significant difference (P < 0.05) between GSI-TEFF cell recipients and WT mice. (D) Cytokine levels in BAL fluid of WT mice that received GSI-TEFF or DMSO-TEFF cells. #, significant difference (P < 0.05) between GSI-TEFF cell recipients and DMSO-TEFF cell recipients; double dagger, significant difference (P < 0.05) between DMSO-TEFF cell recipients and WT control mice; *, significant difference (P < 0.05) between GSI-TEFF cell recipients and WT control mice. (E) Relative expression levels of GATA-3 and T-bet in the lung were determined by quantitative real-time PCR. Lung cells are from the same groups as described in A. They were isolated using collagenase digestion, and RNA was prepared. Results are representative of three independent experiments. The results for each group are expressed as mean +/- SEM. #, significant difference (P < 0.05) between GSI-TEFF cell-transferred mice and DMSO-TEFF cell-transferred mice or WT control mice.
###end p 18
###begin p 19
###xml 68 71 68 71 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 87 90 87 90 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 210 213 210 213 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 287 289 287 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib32">32</xref>
###xml 310 311 310 311 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 402 405 402 405 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 420 423 420 423 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 482 490 482 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 C</xref>
###xml 528 529 528 529 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 600 603 600 603 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 635 638 633 636 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 773 774 767 768 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 805 808 799 802 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 476 480 <span type="species:ncbi:10090">mice</span>
###xml 701 705 <span type="species:ncbi:10090">mice</span>
Cell composition of BAL fluid was examined in WT recipients of GSI-TEFF cells or DMSO-TEFF cells by flow cytometry 48 h after the secondary challenge. Previous studies demonstrated that adoptively transferred TEFF cells preferentially migrated into allergen-challenged airways via BLT1 (32). The numbers of CD8+ T cells in the BAL fluid were increased to a similar extent in recipients of either DMSO-TEFF cells or GSI-TEFF cells compared with secondary challenged WT control mice (Fig. 2 C). In addition, the percentages of CD8+ T cells among total BAL cells were higher in both recipients of DMSO-TEFF cells (20.4 +/- 1.7%) and GSI-TEFF cells (19.4 +/- 1.3%) than in secondary challenged WT control mice (6.6 +/- 0.4%). These data demonstrate that the accumulation of CD8+ T cells in the airways after TEFF cell transfer and secondary allergen challenge was not altered by pretreatment with GSI. The results from lung cell digestion were similar to those observed in BAL fluid (Fig. S1, available at ).
###end p 19
###begin title 20
###xml 63 66 63 66 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 82 85 82 85 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 35 39 <span type="species:ncbi:10090">mice</span>
Cytokine levels in BAL fluid of WT mice after transfer of GSI-TEFF cells or DMSO-TEFF cells
###end title 20
###begin p 21
###xml 142 144 142 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib33">33</xref>
###xml 166 169 166 169 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 284 287 284 287 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 323 326 323 326 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 430 438 426 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 D</xref>
###xml 226 230 <span type="species:ncbi:10090">mice</span>
The relative levels of Th1 and Th2 cytokines have been proposed to play an important role in the development of allergic airway inflammation (33). After transfer of TEFF cells pretreated with DMSO into secondary challenged WT mice, IL-4 and IL-13 levels in BAL of recipients of DMSO-TEFF cells were increased, whereas GSI-TEFF cell recipients showed smaller increases in IL-4 and IL-13 but markedly increased levels of IFN-gamma (Fig. 2 D). Similar results on cytokine production were observed when lung cells were assayed (Fig. S2, available at ).
###end p 21
###begin title 22
The expression of T-bet and GATA-3 in homogenized lung
###end title 22
###begin p 23
###xml 153 155 153 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib12">12</xref>
###xml 285 288 285 288 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 304 307 304 307 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 418 421 418 421 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 518 521 518 521 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 567 575 567 575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 E</xref>
###xml 261 265 <span type="species:ncbi:10090">mice</span>
Because the balance between the transcription factors T-bet and GATA-3 has been associated with the predominance of Th1 and Th2 responses, respectively (12), we analyzed levels of these transcription factors using real-time PCR in homogenized lung samples from mice that received GSI-TEFF cells or DMSO-TEFF cells. In parallel to the results of BAL cytokine levels, the expression level of T-bet in recipients of GSI-TEFF cells was significantly higher than in the other groups; the expression level of GATA-3 in GSI-TEFF cell recipients was significantly decreased (Fig. 2 E).
###end p 23
###begin title 24
###xml 27 28 23 24 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 35 36 31 32 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
IFN-gamma production in CD4+ or CD8+ T cells
###end title 24
###begin p 25
###xml 73 76 69 72 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 195 198 191 194 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 214 217 210 213 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 272 279 268 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="tbl1">Table I</xref>
###xml 304 305 296 297 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 322 323 314 315 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 341 344 333 336 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 404 407 396 399 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 476 477 464 465 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 522 525 510 513 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 562 565 550 553 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 583 590 571 578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="tbl1">Table I</xref>
###xml 160 164 <span type="species:ncbi:10090">mice</span>
To identify the source of IFN-gamma production in the recipients of GSI-TEFF cells, mononuclear cells (MNCs) were obtained from the lung tissue of recipient WT mice after transfer of either GSI-TEFF cells or DMSO-TEFF cells 48 h after secondary OVA challenge. As shown in Table I, the number of IFN-gamma+ cells in the CD4+ fraction of GSI-TEFF cell recipients was significantly higher than in the DMSO-TEFF cell recipients. However, the number of IFN-gamma-producing lung CD8+ T cells was significantly decreased in GSI-TEFF cell recipients compared with DMSO-TEFF cell recipients (Table I).
###end p 25
###begin p 26
###xml 19 20 15 16 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 24 25 20 21 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 28 29 24 25 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 42 43 34 35 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 47 48 39 40 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 51 52 43 44 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 129 132 121 124 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 141 144 133 136 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 104 108 <span type="species:ncbi:10090">mice</span>
Number of IFN-gamma+ CD3+CD4+ or IFN-gamma+ CD3+CD8+ cells in the lungs of sensitized and challenged WT mice that received DMSO-TEFF or GSI-TEFF cells
###end p 26
###begin p 27
###xml 80 83 78 81 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 99 102 97 100 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 172 175 170 173 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 190 193 188 191 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 68 72 <span type="species:ncbi:10090">mice</span>
###xml 121 125 <span type="species:ncbi:10090">mice</span>
###xml 212 216 <span type="species:ncbi:10090">mice</span>
Mean values +/- SEM are given. WT, OVA-sensitized and challenged WT mice; DMSO-TEFF, DMSO-treated TEFF cell recipient WT mice that were OVA sensitized and challenged; GSI-TEFF, GSI-treated TEFF cell recipient WT mice that were OVA sensitized and challenged.
###end p 27
###begin p 28
###xml 31 34 31 34 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 61 64 61 64 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
P < 0.05 compared between GSI-TEFF cells versus WT and DMSO-TEFF cells.
###end p 28
###begin p 29
###xml 31 34 31 34 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 54 57 54 57 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
P < 0.05 compared between GSI-TEFF cells versus DMSO-TEFF cells.
###end p 29
###begin title 30
###xml 16 19 16 19 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 88 91 88 91 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
Effects of GSI-TEFF cell transfer on allergen-induced AHR and airway inflammation in CD8-/- recipients
###end title 30
###begin p 31
###xml 1 4 1 4 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 50 53 50 53 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 121 123 121 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib10">10</xref>
###xml 193 196 193 196 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 243 246 243 246 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 262 265 262 265 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 323 326 323 326 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 381 397 381 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 (A and B)</xref>
###xml 402 405 402 405 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 505 508 505 508 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 619 622 619 622 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 643 646 643 646 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 713 716 713 716 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 741 744 741 744 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 759 762 759 762 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 929 932 925 928 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 983 986 979 982 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 1044 1052 1040 1048 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 C</xref>
###xml 54 58 <span type="species:ncbi:10090">mice</span>
###xml 197 201 <span type="species:ncbi:10090">mice</span>
###xml 327 331 <span type="species:ncbi:10090">mice</span>
###xml 406 410 <span type="species:ncbi:10090">mice</span>
TEFF cells transferred into primary challenged CD8-/- mice restored the full development of AHR and airway inflammation (10). To analyze the role of Notch signaling in the reconstitution of CD8-/- mice after secondary allergen challenge, GSI-TEFF cells or DMSO-TEFF cells were transferred into sensitized and challenged CD8-/- mice before secondary allergen challenge. As shown in Fig. 3 (A and B), CD8-/- mice developed significantly lower responses after secondary allergen challenge. Transfer of DMSO-TEFF cells reconstituted the development of AHR and eosinophilic airway inflammation. The development of AHR in CD8-/- recipients of DMSO-TEFF cells was not significantly different from WT recipients of DMSO-TEFF cells. Transfer of GSI-TEFF cells into CD8-/- failed to increase AHR or airway eosinophilia, but it did increase the numbers of neutrophils in BAL fluid. IFN-gamma levels in BAL fluid were also increased in GSI-TEFF cell recipients compared with recipients of DMSO-TEFF cells, whereas the opposite was true for IL-4 and IL-13 (Fig. 3 C).
###end p 31
###begin p 32
###xml 64 67 64 67 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 93 96 93 96 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 116 119 116 119 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 0 126 0 126 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Allergen-induced AHR and airway inflammation are restored in CD8<sup>&#8722;/&#8722;</sup> mice that received DMSO-T<sub>EFF</sub> cells but not GSI-T<sub>EFF</sub> cells.</bold>
###xml 194 197 194 197 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 218 219 218 219 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 225 228 225 228 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 238 241 238 241 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 412 415 412 415 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 453 456 453 456 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 599 600 597 598 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 658 661 656 659 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 688 691 686 689 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 772 775 758 761 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 856 859 842 845 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 68 72 <span type="species:ncbi:10090">mice</span>
###xml 198 202 <span type="species:ncbi:10090">mice</span>
###xml 275 279 <span type="species:ncbi:10090">mice</span>
Allergen-induced AHR and airway inflammation are restored in CD8-/- mice that received DMSO-TEFF cells but not GSI-TEFF cells. Before secondary challenge, sensitized and challenged (primary) CD8-/- mice received 5 x 106 GSI-TEFF or DMSO-TEFF cells via the tail vein. Control mice were sensitized and challenged and received PBS on secondary challenge. (A) AHR. #, significant difference (P < 0.05) between DMSO-TEFF cell recipients and controls or GSI-TEFF cell recipients. (B) Cell composition in BAL fluid and (C) BAL cytokine levels. The results for each group are expressed as the mean +/- SEM (n = 12). #, significant difference (P < 0.05) between GSI-TEFF cell recipients and DMSO-TEFF cell recipients; double dagger, significant difference (P < 0.05) between DMSO-TEFF cell recipients and controls; *, significant difference (P < 0.05) between GSI-TEFF cell recipients and controls.
###end p 32
###begin p 33
###xml 56 59 56 59 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 99 102 99 102 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 118 121 118 121 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 191 199 191 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="tbl2">Table II</xref>
###xml 219 220 219 220 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 229 230 225 226 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 247 250 243 246 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 310 313 306 309 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 382 383 374 375 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 410 413 402 405 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 444 447 436 439 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 584 585 572 573 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 620 623 608 611 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 60 64 <span type="species:ncbi:10090">mice</span>
MNCs were obtained from the lung tissue of recipient CD8-/- mice after the transfer of either GSI-TEFF cells or DMSO-TEFF cells 48 h after secondary challenge and assessed by flow cytometry (Table II). The number of CD4+IFN-gamma+ T cells in GSI-TEFF cell recipients was significantly higher than in the DMSO-TEFF cell recipients. However, the number of IFN-gamma-producing lung CD8+ T cells was lower in GSI-TEFF cell recipients than in DMSO-TEFF cell recipients. Based on these results, it appeared that the source of increased IFN-gamma production and Th1 polarization was lung CD4+ T cells in the recipients of GSI-TEFF cells.
###end p 33
###begin p 34
###xml 19 20 15 16 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 24 25 20 21 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 28 29 24 25 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 42 43 34 35 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 47 48 39 40 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 51 52 43 44 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 104 107 96 99 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 133 136 125 128 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 145 148 137 140 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 108 112 <span type="species:ncbi:10090">mice</span>
Number of IFN-gamma+ CD3+CD4+ or IFN-gamma+ CD3+CD8+ cells in the lungs of sensitized and challenged CD8-/- mice that received DMSO-TEFF or GSI-TEFF cells
###end p 34
###begin p 35
###xml 102 105 100 103 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 121 124 119 122 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 205 208 203 206 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 223 226 221 224 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 90 94 <span type="species:ncbi:10090">mice</span>
###xml 154 158 <span type="species:ncbi:10090">mice</span>
###xml 256 260 <span type="species:ncbi:10090">mice</span>
Mean values +/- SEM are given. CD8-deficient, OVA-sensitized and challenged CD8-deficient mice; DMSO-TEFF, DMSO-treated TEFF cell recipient CD8-deficient mice that were OVA sensitized and challenged; GSI-TEFF, GSI-treated TEFF cell recipient CD8-deficient mice that were OVA sensitized and challenged.
###end p 35
###begin p 36
###xml 31 34 31 34 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 72 75 72 75 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
P < 0.05 compared between GSI-TEFF cells versus CD8-deficient and DMSO-TEFF cells.
###end p 36
###begin p 37
###xml 31 34 31 34 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 54 57 54 57 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
P < 0.05 compared between GSI-TEFF cells versus DMSO-TEFF cells.
###end p 37
###begin title 38
###xml 25 28 25 28 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 43 46 43 46 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 66 69 66 69 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 85 88 85 88 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
Expression of Delta1 in TEFF cells from CD8-/- recipients of GSI-TEFF cells or DMSO-TEFF cells
###end title 38
###begin p 39
###xml 98 99 98 99 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 101 104 101 104 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 167 170 167 170 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 197 200 197 200 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 216 219 216 219 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 315 317 315 317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib34">34</xref>
###xml 329 331 329 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib35">35</xref>
###xml 347 349 347 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib36">36</xref>
###xml 544 547 544 547 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 583 586 583 586 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 594 600 594 600 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4</xref>
###xml 655 658 655 658 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 674 677 674 677 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
To determine if Notch ligand expression was involved in the response of the transferred cells, CD8+ TEFF cells were isolated from the lungs of secondary challenged CD8-/- recipients of either GSI-TEFF cells or DMSO-TEFF cells and analyzed by real-time PCR. T cells are reported to express the Notch ligands Delta1 (34), Jagged1 (35), and Jagged2 (36). In parallel to the data on BAL (and lung cell) cytokine production and the induction of T-bet expression in the lung, we showed that the level of Delta1 expression was higher in isolated GSI-TEFF cells compared with isolated DMSO-TEFF cells (Fig. 4). Baseline levels of Delta1 expression in either GSI-TEFF cells or DMSO-TEFF cells before transfer were extremely low in the absence of activation. There were no significant differences in the levels of expression of the other Notch ligands (Jagged1 and Jagged2).
###end p 39
###begin p 40
###xml 54 57 54 57 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 0 64 0 64 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Real-time PCR analysis of Notch ligand expression in T<sub>EFF</sub> cells.</bold>
###xml 99 102 99 102 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 112 115 112 115 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 126 127 126 127 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 129 132 129 132 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 160 163 160 163 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 496 499 494 497 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 526 529 524 527 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 164 168 <span type="species:ncbi:10090">mice</span>
Real-time PCR analysis of Notch ligand expression in TEFF cells. Before and after transfer of GSI-TEFF or DMSO-TEFF cells, CD8+ TEFF cells from the lungs of CD8-/- mice were isolated using MACS beads and RNA was prepared. The relative expression of Notch ligands (Delta1, Jagged1, and Jagged2) was determined by quantitative real-time PCR. Results are from three independent experiments. The results for each group are expressed as mean +/- SEM. #, significant difference (P < 0.05) between GSI-TEFF cell recipients and DMSO-TEFF cell recipients.
###end p 40
###begin title 41
###xml 45 49 <span type="species:ncbi:10090">mice</span>
Effects of administration of Delta1-Fc to WT mice on allergen-induced AHR and airway inflammation
###end title 41
###begin p 42
###xml 205 213 205 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 A</xref>
###xml 362 370 362 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 B</xref>
###xml 655 670 655 670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5, C and D</xref>
###xml 100 104 <span type="species:ncbi:10090">mice</span>
###xml 136 141 <span type="species:ncbi:9606">human</span>
###xml 307 312 <span type="species:ncbi:9606">human</span>
###xml 395 400 <span type="species:ncbi:9606">human</span>
###xml 437 441 <span type="species:ncbi:10090">mice</span>
###xml 522 526 <span type="species:ncbi:10090">mice</span>
To directly test whether Delta1 regulates AHR and airway inflammation, sensitized and challenged WT mice were treated with Delta1-Fc or human IgG as a control before secondary OVA challenge (OVA/OVA/OVA) (Fig. 5 A). Administration of Delta1-Fc markedly reduced AHR compared with administration of (control) human IgG in response to secondary allergen challenge (Fig. 5 B). Neither Delta1-Fc nor human IgG altered the response in control mice (OVA/OVA/PBS). In parallel, administration of Delta1-Fc to secondary challenged mice markedly reduced the numbers of eosinophils and levels of IL-13 in the BAL fluid without affecting these responses in controls (Fig. 5, C and D).
###end p 42
###begin p 43
###xml 0 90 0 90 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Allergen-induced AHR and airway inflammation are prevented by administration of Delta1-Fc.</bold>
###xml 315 316 311 312 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 330 331 326 327 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 338 339 334 335 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 423 424 417 418 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 154 158 <span type="species:ncbi:10090">mice</span>
###xml 181 186 <span type="species:ncbi:9606">human</span>
###xml 529 533 <span type="species:ncbi:10090">mice</span>
###xml 538 543 <span type="species:ncbi:9606">human</span>
###xml 577 581 <span type="species:ncbi:10090">mice</span>
###xml 593 597 <span type="species:ncbi:10090">mice</span>
Allergen-induced AHR and airway inflammation are prevented by administration of Delta1-Fc. Secondary challenged (OVA/OVA/OVA) or control (OVA/OVA/PBS) WT mice received Delta1-Fc or human IgG. (A) Experimental protocol, (B) AHR, (C) cell composition in BAL fluid, (D) BAL cytokine levels, and (E) number of IFN-gamma+-producing CD4+ or CD8+ T cells in the lung. The results for each group are expressed as the mean +/- SEM (n = 8 in each group). #, significant difference (P < 0.05) between Delta1-Fc-treated secondary challenged mice and human IgG-treated secondary challenged mice or control mice.
###end p 43
###begin p 44
###xml 293 301 285 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 E</xref>
###xml 320 321 312 313 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 330 331 318 319 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 512 513 500 501 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 522 523 506 507 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 532 533 516 517 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 52 56 <span type="species:ncbi:10090">mice</span>
###xml 259 263 <span type="species:ncbi:10090">mice</span>
###xml 275 279 <span type="species:ncbi:10090">mice</span>
###xml 343 347 <span type="species:ncbi:10090">mice</span>
###xml 424 429 <span type="species:ncbi:9606">human</span>
###xml 474 479 <span type="species:ncbi:9606">human</span>
Administration of Delta1-Fc to secondary challenged mice resulted in significantly increased levels of IFN-gamma in the BAL fluid. To confirm these effects of Delta1-Fc and IFN-gamma production, MNCs were obtained from the lung tissue of secondary challenged mice or control mice. As shown in Fig. 5 E, the number of CD4+IFN-gamma+ T cells in mice treated with Delta1-Fc was significantly higher than in those that received human IgG (or controls that received Delta1-Fc or human IgG). However, the number of CD8+IFN-gamma+ lung CD8+ T cells was not significantly different among any of these groups. The results in BAL fluid were confirmed using lung cells (Fig. S3, available at ).
###end p 44
###begin title 45
DISCUSSION
###end title 45
###begin p 46
###xml 144 146 144 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib37">37</xref>
###xml 148 150 148 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib38">38</xref>
###xml 577 579 577 579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib16">16</xref>
###xml 581 583 581 583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib39">39</xref>
###xml 584 586 584 586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib41">41</xref>
###xml 655 656 655 656 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 739 741 739 741 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib21">21</xref>
###xml 828 830 828 830 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib25">25</xref>
###xml 832 834 832 834 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib26">26</xref>
The Notch signaling pathway is a highly conserved program for cell fate decisions in all organisms, influencing apoptosis or cell cycle arrest (37, 38). The signal induced by ligand binding is conveyed intracellularly by a process involving proteolytic cleavage of the receptor and nuclear translocation of the intracellular domain of the Notch family protein. The GSIs prevent the generation of the NICD and suppress Notch activity. In the immune system, several studies have implicated Notch signaling in hematopoiesis, T-B lineage commitment, and thymic T cell development (16, 39-41). Notch gene expression is induced and Notch1 is activated after CD4+ T cell activation, possibly through a "positive feedback loop" in adjacent cells (21). Studies have also suggested that Notch may influence both Th1 and Th2 polarization (25, 26).
###end p 46
###begin p 47
###xml 73 74 73 74 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 203 204 203 204 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 288 289 288 289 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 317 319 317 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib23">23</xref>
###xml 321 323 321 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib42">42</xref>
###xml 360 362 360 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib20">20</xref>
###xml 415 416 411 412 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 548 549 544 545 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
In contrast to several reports that analyzed the relationship between CD4+ T cells and Notch in the peripheral immune system, there is a paucity of information regarding a role for Notch signaling in CD8+ T cells. Several studies have suggested that the activation of Notch suppresses CD8+ T cell effector functions (23, 42). On the other hand, Palaga et al. (20) reported that the number of IFN-gamma-producing CD8+ T cells was significantly reduced by inhibition of Notch signaling, indicating that the activation of Notch may be required for CD8+ T cell function.
###end p 47
###begin p 48
###xml 56 57 56 57 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 70 71 70 71 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 131 132 131 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib7">7</xref>
###xml 133 135 133 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib10">10</xref>
###xml 137 139 137 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib43">43</xref>
###xml 140 142 140 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib45">45</xref>
###xml 170 171 170 171 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 226 227 226 227 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 287 289 287 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib11">11</xref>
###xml 321 324 321 324 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 483 484 483 484 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 560 561 560 561 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 563 566 563 566 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 585 586 585 586 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 588 590 588 590 <sub xmlns:xlink="http://www.w3.org/1999/xlink">CM</sub>
###xml 616 617 616 617 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib9">9</xref>
###xml 619 621 619 621 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib10">10</xref>
###xml 650 653 650 653 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 678 680 678 680 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib32">32</xref>
###xml 720 722 720 722 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib46">46</xref>
###xml 779 782 779 782 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 862 864 862 864 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib32">32</xref>
###xml 325 329 <span type="species:ncbi:10090">mice</span>
###xml 405 409 <span type="species:ncbi:10090">mice</span>
There is now increasing evidence that in addition to CD4+ T cells, CD8+ T cells contribute to the development of allergic disease (7-10, 43-45). In the development of CD8+ T cell-mediated AHR and eosinophilic inflammation, CD4+ T cells play an essential role in the sensitization phase (11). We previously showed that CD8-/- mice develop lower levels of AHR and eosinophilic inflammation compared with WT mice, and these responses can be restored by transfer of in vivo-activated CD8+ T cells from antigen-primed donors or by transfer of in vitro-generated CD8+ TEFF cells, but not CD8+ TCM cells, before challenge (9, 10). Recently, we showed that TEFF cells up-regulate BLT1 (32), the high affinity receptor for LTB4 (46), and BLT1 plays a critical role in the recruitment of TEFF cells into allergen-challenged lungs resulting in AHR and airway inflammation (32).
###end p 48
###begin p 49
###xml 98 101 98 101 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 107 109 107 109 <sub xmlns:xlink="http://www.w3.org/1999/xlink">CM</sub>
###xml 187 188 187 188 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 190 193 190 193 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 200 202 200 202 <sub xmlns:xlink="http://www.w3.org/1999/xlink">CM</sub>
###xml 350 353 350 353 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 482 483 482 483 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 485 488 485 488 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 628 631 628 631 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
In this study, we used transcript expression profile analysis to define gene differences between TEFF and TCM cells. In light of the findings that Notch1 expression was much higher in CD8+ TEFF than TCM cells, we investigated the role of this signaling molecule in CD8-mediated allergic airway responses. We first demonstrated that Notch can signal TEFF cells and determined the role of this signaling pathway using a pharmacological approach. We showed that after incubation of CD8+ TEFF cells with anti-CD3/anti-CD28 or the addition of SIINFEKL, cleaved Notch1 could be detected confirming Notch signaling, and incubation of TEFF cells with the GSI prevented this cleavage in vitro.
###end p 49
###begin p 50
###xml 259 260 259 260 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 262 265 262 265 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 273 275 273 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib27">27</xref>
###xml 416 419 416 419 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 549 552 549 552 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 850 853 846 849 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 980 983 976 979 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 1179 1181 1167 1169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib47">47</xref>
###xml 1183 1185 1171 1173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib48">48</xref>
###xml 1281 1283 1265 1267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib49">49</xref>
###xml 1370 1372 1350 1352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib50">50</xref>
###xml 1393 1395 1373 1375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib51">51</xref>
###xml 613 617 <span type="species:ncbi:10090">mice</span>
These observations were extended to assess the effects of preventing Notch cleavage in vivo. To effectively maintain GSI interference, we used a secondary challenge protocol in which the analysis of AHR was completed within 48 h of transfer of GSI-treated CD8+ TEFF cells (27). In sensitized and challenged WT recipients, secondary challenge elicited AHR and airway inflammation. Transfer of DMSO (control)-treated TEFF cells led to further increases in AHR, airway eosinophilia, and BAL IL-4 and IL-13 levels. In contrast, transfer of GSI-treated TEFF cells failed to enhance the responses over those seen in WT mice. Notably, levels of BAL IFN-gamma were markedly increased in these recipients as were the levels of expression of T-bet with a decrease in GATA-3 expression. These results were not attributable to differences in the ability of GSI-TEFF cells to accumulate in the lung, as the numbers of GSI- and DMSO-treated cells in the lung were the same. The failure of GSI-TEFF cells to enhance AHR or eosinophilic airway inflammation could be attributed to the increases in IFN-gamma production. We previously demonstrated that IFN-gamma has the potential to inhibit AHR (47, 48) and that intranasal administration of IFN-gamma effectively inhibited goblet cell metaplasia (49). Additionally, IFN-gamma has been shown to inhibit airway smooth muscle contraction (50) and proliferation (51).
###end p 50
###begin p 51
###xml 147 149 147 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib52">52</xref>
###xml 324 326 320 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib52">52</xref>
###xml 440 442 436 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib53">53</xref>
###xml 444 446 440 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib54">54</xref>
###xml 497 499 489 491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib55">55</xref>
###xml 561 564 553 556 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 806 809 798 801 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
Differentiation of Th1 and Th2 cells is tightly cross-regulated so that development of one subset is inhibited by cytokines produced by the other (52). T-box expressed in T cells (T-bet) plays a central role in Th1 development by activating Th1 genetic programs, IFN-gamma production, and repressing Th2 cytokine synthesis (52). In contrast, GATA-3 serves as a Th2 cytokine-specific transcription factor selectively expressed in Th2 cells (53, 54) and leads to inhibition of IFN-gamma production (55). In the secondary challenge model, transfer of GSI-treated TEFF cells shifted the balance with modest increases and decreases in T-bet and GATA-3, respectively, accompanied by failure to enhance lung allergic responses. However, the balance was not shifted to the extent that the transfer of GSI-treated TEFF cells prevented sensitized and challenged host cells from contributing to the lung allergic responses.
###end p 51
###begin p 52
###xml 33 36 33 36 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 79 82 79 82 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 111 114 111 114 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 238 241 238 241 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 332 335 328 331 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 600 603 596 599 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 709 712 705 708 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 744 745 740 741 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 747 750 743 746 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 809 812 805 808 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 876 879 872 875 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 949 952 945 948 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1044 1047 1040 1043 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 953 957 <span type="species:ncbi:10090">mice</span>
A similar pattern was seen in CD8-/- recipients where transfer of GSI-treated TEFF cells, unlike DMSO-treated TEFF cells, failed to reconstitute AHR, airway eosinophilia, or BAL IL-13 levels. As in WT recipients, transfer of GSI-treated TEFF cells resulted in increased IFN-gamma levels in BAL. In vitro, incubation of GSI-treated TEFF cells with anti-CD3/anti-CD28 or SIINFEKL did lead to decreased expression of Notch1 mRNA (unpublished data), in keeping with the reduced levels of Notch1 cleavage protein determined by Western blotting. In parallel, activation through the TCR of the GSI-treated TEFF cells led to increases in the expression of Delta1 mRNA. However, these changes were only seen when GSI-TEFF cells were co-cultured with CD8+ TEFF cells during the activation period, but not when the GSI-TEFF cells were cultured alone (Fig. S4, available at ). After GSI-TEFF cell transfer and recovery from the lungs of secondary challenged CD8-/- mice, we noted a marked up-regulation of Delta1 mRNA compared with recovered DMSO-treated TEFF cells, with little or no difference between the two in levels of Jagged1 or Jagged2 mRNA.
###end p 52
###begin p 53
###xml 130 132 130 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib56">56</xref>
###xml 134 136 134 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib57">57</xref>
###xml 220 222 220 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib34">34</xref>
###xml 249 251 249 251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib35">35</xref>
###xml 253 255 253 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib36">36</xref>
###xml 282 283 282 283 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 392 394 392 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib25">25</xref>
###xml 484 486 484 486 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib26">26</xref>
Notch-Notch ligand interactions govern cell fate decisions in T cells. Notch signaling can direct Th2 differentiation via GATA-3 (56, 57). In vertebrates, Notch can bind to two different families of ligands, Delta-like (34) and Jagged1 and Jagged2 (35, 36). Stimulation of naive CD4+ T cells with Delta1 involving interactions with Notch3 promotes the differentiation toward the Th1 pathway (25), whereas Jagged1-mediated Notch1 activation is critical in driving Th2 differentiation (26). As a rule, the ligands tend to be expressed in a more highly restricted pattern than their receptors.
###end p 53
###begin p 54
###xml 27 28 27 28 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 30 33 30 33 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 525 526 521 522 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 596 598 588 590 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib20">20</xref>
###xml 655 658 643 646 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 754 757 742 745 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 873 874 857 858 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 922 923 906 907 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 932 933 912 913 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1015 1016 995 996 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1022 1025 1002 1005 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 1071 1074 1051 1054 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 1120 1121 1100 1101 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1155 1156 1135 1136 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1179 1187 1159 1167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 C</xref>
###xml 1244 1247 1224 1227 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 1264 1267 1244 1247 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 1371 1374 1351 1354 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 1487 1488 1467 1468 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1497 1498 1473 1474 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1606 1607 1582 1583 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1675 1676 1647 1648 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1686 1688 1658 1660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib25">25</xref>
###xml 1690 1692 1662 1664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib26">26</xref>
###xml 1531 1535 <span type="species:ncbi:10090">mice</span>
These effects of GSI on CD8+ TEFF cells decreasing Notch1 expression, reducing Notch1 cleavage, and increasing T-bet and Delta1 expression, and the associated inhibition of enhancement or failure to restore lung allergic responses together with increased IFN-gamma production, indicated that Notch-Delta1 pathways were critical regulators of AHR and Th2 lung allergic responses. The GSI reduced the amount of Notch signaling to potentially mimic a Notch1 loss of function phenotype. It appears that activated T cells, and CD8+ T cells in particular, pretreated with GSI produce little IFN-gamma (20). We analyzed IFN-gamma secretion in TCR-activated GSI-TEFF cells and found production to be significantly decreased compared with similarly treated DMSO-TEFF cells (Fig. S5, available at ). After transfer, the majority of IFN-gamma-producing cells were localized to the CD4+ subset. The data imply that the increase in CD4+IFN-gamma+ T cells resulted from the changes in Notch signaling ligands expressed on the CD8+ GSI-TEFF cells, i.e., up-regulation of Delta1 on GSI-TEFF cells interacting with Notch receptors on CD4+ T cells. The total numbers of CD4+ T cells in BAL fluid (Fig. 2 C) and lung (Fig. S1) were the same in recipients of GSI-TEFF cells and DMSO-TEFF cells. However, only after the interactions mediated through Notch receptors and Notch ligands on GSI-TEFF cells was attenuation of CD8-mediated AHR and inflammation observed and associated with increased numbers of CD4+IFN-gamma+ T cells in secondary challenged mice. These data are consistent with reports that Delta1 interacts with CD4+ T cells and enhances IFN-gamma production in antigen-stimulated CD4+ T cells (25, 26).
###end p 54
###begin p 55
###xml 211 212 207 208 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 592 594 584 586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib58">58</xref>
###xml 693 694 681 682 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 938 939 926 927 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 948 949 932 933 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 605 609 <span type="species:ncbi:10090">mice</span>
###xml 1064 1068 <span type="species:ncbi:10090">mice</span>
To further extend these observations, we examined the consequences of administering a Delta1-Fc protein before secondary challenge. Administration of Delta1-Fc resulted in increased IFN-gamma production from CD4+ T cells, and this was associated with a significant inhibition of the development of AHR, airway eosinophilia, and BAL IL-13 levels. At the same time, BAL IFN-gamma levels were increased. These results are similar to recent observations in experimental autoimmune encephalomyelitis, where treatment with Delta1-Fc increased the number of Th1 cells in the central nervous system (58). Control mice that received Delta1-Fc did not increase the number of IFN-gamma-producing lung CD4+ T cells, suggesting that in the absence of activation, the expression of Notch is not up-regulated and that interactions between Notch receptor and Delta1-Fc do not take place. In recipients of Delta1-Fc, we detected the highest numbers of CD4+IFN-gamma+ T cells and levels of IFN-gamma, accompanied by markedly reduced levels of IL-4 and IL-13 in secondary challenged mice (Fig. S3).
###end p 55
###begin p 56
###xml 28 29 28 29 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 31 34 31 34 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 78 80 78 80 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib10">10</xref>
###xml 82 84 82 84 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib32">32</xref>
###xml 153 154 153 154 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 308 309 308 309 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 319 321 319 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib59">59</xref>
###xml 422 423 422 423 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 425 428 425 428 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 535 536 531 532 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 627 628 623 624 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 632 633 628 629 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 261 265 <span type="species:ncbi:10090">mice</span>
After adoptive transfer, CD8+ TEFF cells in the lung exhibit a Th2 phenotype (10, 32). Thus, the phenotype of predominant Th1-type cytokine-producing CD8+ T cells could be redirected toward Th2-type cytokine production in the lungs of sensitized and challenged mice, a plasticity previously emphasized in CD4+ T cells (59). As a result of the inhibition of Notch signaling by GSI, Th2 cytokine production by these lung CD8+ TEFF cells was superseded by Notch receptor-Notch ligand interactions and increased IFN-gamma production in CD4+ T cells. Collectively, these data identify a new pathway involved in the regulation of CD4+-CD8+ T cell interactions and the development of Th2-mediated allergic responses through Notch signaling. The pathway appears tightly regulated by the expression pattern of Notch receptor and the Delta1 Notch ligand, which are in turn dependent on the activation of T cells. The data reveal the therapeutic potential of Delta1-Fc in the regulation of allergen-induced AHR.
###end p 56
###begin title 57
MATERIALS AND METHODS
###end title 57
###begin title 58
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice.
###end title 58
###begin p 59
###xml 94 101 94 101 <sub xmlns:xlink="http://www.w3.org/1999/xlink">257&#8211;264</sub>
###xml 122 124 122 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib60">60</xref>
###xml 199 202 199 202 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 237 245 237 241 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD8&#945;</italic>
###xml 274 276 270 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib61">61</xref>
###xml 455 456 451 452 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 20 24 <span type="species:ncbi:10090">mice</span>
###xml 204 208 <span type="species:ncbi:10090">mice</span>
###xml 268 272 <span type="species:ncbi:10090">mice</span>
###xml 443 447 <span type="species:ncbi:10090">mice</span>
###xml 505 509 <span type="species:ncbi:10090">mice</span>
WT C57BL/6 and OT-1 mice (C57BL/6 strain) expressing a transgenic TCR that is specific for OVA257-264 (SIINFEKL) peptide (60) were purchased from The Jackson Laboratory. Homozygous CD8-deficient (CD8-/-) mice, generated by targeting the CD8alpha chain gene in C57BL/6 mice (61), were obtained from P. Marrack (National Jewish Medical and Research Center, Denver, CO). Each experiment was independently performed at least three times with four mice/group (n = 12). Controls were matched with the deficient mice with regard to both age and gender in each experimental group. All studies were conducted under a protocol approved by the Institutional Animal Care and Use Committee of the National Jewish Medical and Research Center.
###end p 59
###begin title 60
Cell (CD8 T cell) preparation and culture.
###end title 60
###begin p 61
###xml 20 23 20 23 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 29 31 29 31 <sub xmlns:xlink="http://www.w3.org/1999/xlink">CM</sub>
###xml 86 88 86 88 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib62">62</xref>
###xml 90 92 90 92 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib63">63</xref>
###xml 122 125 122 125 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 284 287 284 287 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 516 519 512 515 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 602 605 598 601 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
Differentiation of TEFF and TCM cells in vitro was performed as described previously (62, 63). For proliferation assays, TEFF cells on day 6 were cultured with GSI or DMSO and IL-2 for 24 h, followed by cell count analysis (Coulter Counter). For the protein and RNA assays, isolated TEFF cells were stimulated with 2 mug/ml of plate-bound anti-CD3 plus 2 mug/ml anti-CD28 (R&D Systems) or 1 mug/ml SIINFEKL peptide in the presence of DMSO (0.1% final concentration) or 20 muM GSI (dibenzapine; EMD) for 24 h. These TEFF cells were washed for immunoblot analysis, or total RNA was extracted from these TEFF cells and analyzed by real-time PCR. All data were representative of at least three independent experiments.
###end p 61
###begin title 62
Preparation of RNA for microarray analysis.
###end title 62
###begin p 63
###xml 24 27 24 27 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 33 35 33 35 <sub xmlns:xlink="http://www.w3.org/1999/xlink">CM</sub>
###xml 162 168 <span type="species:ncbi:10090">murine</span>
RNA was extracted from TEFF and TCM cells using the TRIzol reagent as per the manufacturer's instructions, and microarray hybridizations were performed using the murine MGU74Av2 Gene Chip (Affymetrix). GENESPRING 5.1 was used to analyze resulting data. Gene lists were generated by comparing raw data values of each cell using one-way analysis of variance (P < 0.05 with a Benjamini-Hochberg correction).
###end p 63
###begin title 64
Western blot analysis.
###end title 64
###begin p 65
###xml 336 347 <span type="species:ncbi:3704">horseradish</span>
Proteins were resolved by SDS-PAGE and transferred to nitrocellulose membranes. The membranes were treated as recommended by the antibody manufacturer for cleaved Notch1 (Val1744; Cell Signaling Technology). For detection of the specific protein, a sensitive chemiluminescence method was used with an appropriate IgG antibody linked to horseradish peroxidase antibody (Thermo Fisher Scientific).
###end p 65
###begin title 66
Sensitization and challenge.
###end title 66
###begin p 67
###xml 96 98 96 98 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib27">27</xref>
###xml 101 105 <span type="species:ncbi:10090">Mice</span>
###xml 283 287 <span type="species:ncbi:10090">mice</span>
###xml 388 392 <span type="species:ncbi:10090">mice</span>
The experimental protocol for sensitization and challenge to allergen was described previously (27). Mice were challenged (primary) via the airways with OVA (0.2% in saline) for 20 min on days 14, 15, and 16 using an ultrasonic nebulizer (model NE-U07; Omron Healthcare). On day 30, mice received a single secondary challenge via the airways with 1% OVA for 20 min (OVA/OVA/OVA). Control mice were sensitized and challenged to OVA, and on day 30 they received PBS (OVA/OVA/PBS). On day 32, airway function was measured as described below, followed by collection of samples for further analyses.
###end p 67
###begin title 68
Assessment of airway function.
###end title 68
###begin p 69
###xml 128 130 128 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib31">31</xref>
Airway function was assessed as described previously by measuring changes in RL in response to increasing doses of inhaled MCh (31). Data are expressed as percent change from baseline RL values obtained after inhalation of saline.
###end p 69
###begin title 70
BAL.
###end title 70
###begin p 71
###xml 153 154 153 154 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 162 163 162 163 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
Immediately after measurement of AHR, lungs were lavaged with HBSS and total leukocyte numbers were analyzed. BAL fluid was collected, and numbers of CD4+ and CD8+ T cells were analyzed by flow cytometry.
###end p 71
###begin title 72
###xml 34 37 34 37 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
Adoptive transfer of GSI-treated TEFF cells and administration of Delta1-Fc.
###end title 72
###begin p 73
###xml 29 30 29 30 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 32 35 32 35 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 68 71 68 71 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 94 97 94 97 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 206 209 206 209 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 428 431 428 431 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 510 512 510 512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib25">25</xref>
###xml 514 516 514 516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib64">64</xref>
###xml 210 214 <span type="species:ncbi:10090">mice</span>
###xml 275 279 <span type="species:ncbi:10090">mice</span>
###xml 432 436 <span type="species:ncbi:10090">mice</span>
###xml 651 655 <span type="species:ncbi:10090">mice</span>
###xml 745 750 <span type="species:ncbi:9606">human</span>
For adoptive transfer, 5 x 106 TEFF cells pretreated with GSI (GSI-TEFF cells) or DMSO (DMSO-TEFF cells) were administered intravenously through the tail vein to OVA primary sensitized/challenged WT and CD8-/- mice 2 wk after the last challenge (day 30). After transfer, the mice were exposed to a single (secondary) allergen challenge via the airways on day 30. All assays were performed on day 32. The nontransferred WT or CD8-/- mice were assigned as controls. In the Delta1-Fc protocol, soluble Delta1-Fc (25, 64) was injected intraperitoneally at a dose of 50 mug each day beginning 4 d before and through the day after secondary challenge in WT mice that had undergone primary sensitization and challenge with OVA. As a control, 50 mug of human IgG was administered in the same manner. 48 h after the single (secondary) allergen challenge, all assays were performed.
###end p 73
###begin title 74
Measurement of cytokines.
###end title 74
###begin p 75
###xml 111 113 111 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib65">65</xref>
Cytokine levels in the BAL fluid and cell culture supernatants were measured by ELISA as described previously (65). The limits of detection were 4 pg/ml for IL-4, IL-5, and IL-13 and 10 pg/ml for IL-10 and IFN-gamma.
###end p 75
###begin title 76
Lung cell isolation and flow cytometry.
###end title 76
###begin p 77
###xml 91 93 91 93 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib66">66</xref>
###xml 215 216 215 216 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 224 225 224 225 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 741 742 732 733 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 749 750 740 741 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
MNCs from the left lung were isolated as described previously using collagenase digestion (66). BAL cells and enriched lung MNCs were labeled with anti-CD3, anti-CD4, and anti-CD8 (BD Biosciences). The number of CD4+ and CD8+ T cells per BAL was derived by multiplying the percentage of stained cells by the total number of BAL cells isolated. For intracellular staining, lung MNCs were stimulated with 5 ng/ml PMA and 500 ng/ml ionomycin (Sigma-Aldrich) for 6 h in the presence of 10 mug/ml brefeldin A (Sigma-Aldrich). After staining for cell surface markers, cells were fixed with 4% paraformaldehyde in PBS, permeabilized in 0.1% saponin, and stained for intracytoplasmic IFN-gamma (BD Biosciences). The number of IFN-gamma-producing CD4+ or CD8+ T cells per lung was calculated from the percentage of total cells. Stained cells were analyzed on a FACSCalibur (BD Bioscience) using CELLQuest software.
###end p 77
###begin title 78
###xml 18 21 18 21 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 31 34 31 34 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
Isolation of GSI-TEFF or DMSO-TEFF cells from the lungs of sensitized and challenged recipients.
###end title 78
###begin p 79
###xml 58 61 58 61 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 86 89 86 89 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 99 102 99 102 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 140 141 140 141 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 286 287 286 287 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 293 296 293 296 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 306 309 306 309 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 62 66 <span type="species:ncbi:10090">mice</span>
Lung MNCs were isolated from sensitized and challenged CD8-/- mice that received GSI-TEFF or DMSO-TEFF cells before secondary challenge. CD8+ T cells were positively selected using magnetic beads coated with anti-CD8 antibody (Miltenyi Biotec). RNA was extracted from these isolated CD8+ GSI-TEFF or DMSO-TEFF cells and analyzed by real-time PCR.
###end p 79
###begin title 80
Real-Time PCR.
###end title 80
###begin p 81
###xml 38 44 <span type="species:ncbi:10090">murine</span>
Real-time cDNA primers and probes for murine T-bet, GATA-3, Delta1, Jagged1, Jagged2, and GAPDH were obtained from Applied Biosystems. The Delta Delta cycle threshold method was performed for relative quantification of mRNA expression.
###end p 81
###begin title 82
Statistical analysis.
###end title 82
###begin p 83
###xml 225 226 223 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink">U</italic>
All results were expressed as the mean +/- SEM as a standard method of presentation for this type of data. The Tukey-Kramer test was used for comparisons between multiple groups. Nonparametric analysis using the Mann-Whitney U test was also used to confirm that the statistical differences remained significant even if the underlying distribution was uncertain. The p-values for significance were set to 0.05 for all tests.
###end p 83
###begin title 84
Online supplemental material.
###end title 84
###begin p 85
###xml 31 32 31 32 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 40 41 40 41 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 89 92 89 92 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 101 104 101 104 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 198 201 198 201 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 210 213 210 213 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 360 363 360 363 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 372 375 372 375 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 406 409 406 409 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
###xml 460 463 456 459 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EFF</sub>
Fig. S1 shows the number of CD4+ and CD8+ T cells in the lungs of WT recipients of DMSO-TEFF or GSI-TEFF cells. Fig. S2 illustrates cytokine production from the lung cells of WT recipients of DMSO-TEFF or GSI-TEFF cells. Fig. S3 illustrates cytokine production from lung cells in the recipients of Delta1-Fc. Fig. S4 shows expression levels of Delta1 on DMSO-TEFF or GSI-TEFF cells cultured together with TEFF cells. Fig. S5 shows IFN-gamma production in GSI-TEFF cells. Figs. S1-S5 are available at .
###end p 85
###begin title 86
Supplementary Material
###end title 86
###begin title 87
[Supplemental Material Index]
###end title 87
###begin p 88
The assistance of Ms. Diana Nabighian in the preparation of this manuscript is gratefully acknowledged.
###end p 88
###begin p 89
This work was supported by National Institutes of Health grants HL-36577 and HL-61005, and by EPA grant R825702. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NHLBI or the NIH.
###end p 89
###begin p 90
The authors have no conflicting financial interests.
###end p 90

